Patient Focused
Number of people who are living with, or in remission from, blood cancer in the United States
What is 1.3 million
Amount that LLS has invested in blood cancer research since our founding in 1949
What is almost $1.3 billion
Name at least five (non-blood) cancers that are benefiting from blood cancer therapy research and approved treatments
What are bladder, bone, brain, breast, colon, colorectal, kidney, liver, lung, melanoma, ovarian, pancreatic, prostate, stomach, skin cancers
The reason people give money to a cause
What is because they are asked
Name the blood cancers
What are leukemia, lymphoma, and myeloma
The three pillars of LLS's mission work
What are research, patient education and support (or patient access), and advocacy
LLS _____ research based on unmet medical needs, and _____ it at every stage - from bench to bedside.
What are prioritizes and supports
Many lifesaving breakthroughs started in blood cancers and are now helping patients with other cancers and serious diseases. Why?
What is blood cells are easier to access and study than cancer cells in solid tumors
Name three campaigns that LLS organizes to raise money for our mission
What are Students of the Year, Man & Woman of the Year, Light The Night, Pennies for Patients, Team in Training, Leukemia Cup Regatta
An agency of the US federal government that approves or disapproves new drugs and substances that can be consumed
What is the Food and Drug Administration (FDA)
1-800-955-4572
What is the Information Resource Center (IRC)
Our total blood cancer research commitment in 2018 exceeded $____ through ___ (#)___ multi-year grants and research partnerships.
What are $188M and 255
The number of therapies approved for blood cancers since 2017
What is 45... and counting
The cents per dollar that go directly to LLS's mission activities
What is 79.5 cents
Less than ___% of cancer patients enroll in a clinical trial. Our rate goes to approximately ___% after a patient talks to one of our clinical trial support center specialists.
What are 5% and 66%
The number one reason most patients call the Information Resource Center (IRC)
What is financial assistance
The new type of immunotherapy developed by Dr. Carl June and his team, in which modified T cells attack cancer cells (also called a "living drug")
What is CAR-T cell therapy
The length of time it takes our Beat AML partner Foundation Medicine to run the genetic typing for a patient (Hint: in 2001, it took ten years.)
What is seven days
True or false: Funds raised through campaigns like LTN are restricted (i.e. designated for a specific mission use within LLS)
What is false: We depend on those dollars being unrestricted, so that we may allocate them to the areas that need the most investment at that time.
The number of languages the IRC specialists can provide support in
What is 170
International collaborative effort, led by LLS, centered on understanding the unique biology of children's leukemias to bring precision medicine revolution to pediatric patients
What is The LLS Children's Initiative (specifically, the PedAL Master Trial)
Strategic initiative through which LLS partners directly with biotechnology companies and medical institutions to help accelerate the development of promising therapies
What is the Therapy Acceleration Program (TAP)
LLS's first master clinical trial, currently operating at 16 sites nationwide, with 11 treatment arms running concurrently, using therapies from seven different companies, using genetic testing to assign all patients to the relevant arm, for newly diagnosed patients aged 60 and over
What is the Beat AML Master Trial
Why LLS is so focused on funding research for cures and better therapies, and not promoting lifestyle changes
What is because there are currently no means of preventing blood cancers
Name at least four resources our IRC specialists provide to patients and caregivers
What are financial and emotional support, clinical trial searches, support groups, podcasts, peer to peer connections, online chats, personalized nutrition consults, conferences, seminars, webcasts, booklets and up to date disease and treatment information